Cubist Systematic Strategies’s Bionano Genomics BNGO Stock Holding History

Cubist Systematic Strategies’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Hold	0	–	-$6	–	3030
2024 Q1	–	Hold	0	–	–	–	3621
2023 Q3	–	Sell	-682	Closed	-$250K	–	3361
2023 Q2	$250K	Buy	+682	New	+$308K	﹤0.01%	2708
2023 Q1	–	Sell	-164	Closed	-$144K	–	3921
2022 Q4	$144K	Buy	+164	New	+$206K	﹤0.01%	3709
2022 Q2	–	Sell	-18	Closed	-$28K	–	4361
2022 Q1	$28K	Sell	18 -14	-44%	-$18.9K	﹤0.01%	3449
2021 Q4	$57K	Sell	32 -128	-80%	-$342K	﹤0.01%	3290
2021 Q3	$528K	Buy	160 +72	+82%	+$252K	0.01%	2002
2021 Q2	$385K	Sell	88 -367	-81%	-$1.45M	﹤0.01%	2177
2021 Q1	$2.21M	Buy	455 +417	+1,097%	+$2.35M	0.03%	970
2020 Q4	$70K	Buy	+38	New	+$14.2K	﹤0.01%	2439

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Cubist Systematic Strategies's BNGO Position: Q2 2024 in Review

Cubist Systematic Strategies held its Bionano Genomics (BNGO) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3030.

Cubist Systematic Strategies first reported a position in BNGO in Q4 2020 and has held it in 8 quarters since. The position peaked at $2.21M in Q1 2021. 53 funds tracked by Wall St. Rank hold BNGO as of Q2 2024.

Cubist Systematic Strategies held 0 shares of Bionano Genomics worth $0 as of Q2 2024.
Cubist Systematic Strategies left its Bionano Genomics share count unchanged in Q2 2024.
Bionano Genomics made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q2 2024, its #3030 holding.
Cubist Systematic Strategies first reported a position in Bionano Genomics in Q4 2020 and has held it in 8 quarters since.
Cubist Systematic Strategies's Bionano Genomics position peaked at $2.21M in Q1 2021.
53 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.